LPI-deepGBDT: a multiple-layer deep framework based on gradient boosting decision trees for lncRNA–protein interaction identification

Abstract

Background Long noncoding RNAs (lncRNAs) play important roles in various biological and pathological processes. Discovery of lncRNA–protein interactions (LPIs) contributes to understand the biological functions and mechanisms of lncRNAs. Although wet experiments find a few interactions between lncRNAs and proteins, experimental techniques are costly and time-consuming. Therefore, computational methods are increasingly exploited to uncover the possible associations. However, existing computational methods have several limitations. First, majority of them were measured based on one simple dataset, which may result in the prediction bias. Second, few of them are applied to identify relevant data for new lncRNAs (or proteins). Finally, they failed to utilize diverse biological information of lncRNAs and proteins. Results Under the feed-forward deep architecture based on gradient boosting decision trees (LPI-deepGBDT), this work focuses on classify unobserved LPIs. First, three human LPI datasets and two plant LPI datasets are arranged. Second, the biological features of lncRNAs and proteins are extracted by Pyfeat and BioProt, respectively. Thirdly, the features are dimensionally reduced and concatenated as a vector to represent an lncRNA–protein pair. Finally, a deep architecture composed of forward mappings and inverse mappings is developed to predict underlying linkages between lncRNAs and proteins. LPI-deepGBDT is compared with five classical LPI prediction models (LPI-BLS, LPI-CatBoost, PLIPCOM, LPI-SKF, and LPI-HNM) under three cross validations on lncRNAs, proteins, lncRNA–protein pairs, respectively. It obtains the best average AUC and AUPR values under the majority of situations, significantly outperforming other five LPI identification methods. That is, AUCs computed by LPI-deepGBDT are 0.8321, 0.6815, and 0.9073, respectively and AUPRs are 0.8095, 0.6771, and 0.8849, respectively. The results demonstrate the powerful classification ability of LPI-deepGBDT. Case study analyses show that there may be interactions between GAS5 and Q15717, RAB30-AS1 and O00425, and LINC-01572 and P35637. Conclusions Integrating ensemble learning and hierarchical distributed representations and building a multiple-layered deep architecture, this work improves LPI prediction performance as well as effectively probes interaction data for new lncRNAs/proteins.

NNAN: Nearest Neighbor Attention Network to Predict Drug–Microbe Associations

“…However, the acquisition of DMAs needs a large scale of assays with high costs, low efficiency, and culturing limitations, and that are time-consuming. To identify DMAs rapidly and effectively, machine learning methods, especially deep learning-based methods, have attracted many scientists due to their inspiring applications in other areas [e.g., predicting microbe–disease associations ( He et al, 2018 ; Peng et al, 2018 ), drug–drug interactions ( Yu et al, 2021a ), lncRNA–miRNA interactions ( Zhang L. et al, 2021 ), and lncRNA–protein interactions ( Lihong et al, 2021 ; Zhou et al, 2021 )].…”

Predicting circRNA-drug sensitivity associations via graph attention auto-encoder

“…LPI-DLDN integrates various biological features and can effectively reduce prediction errors. Zhou et al proposed a gradient-boosting decision trees-based multi-layer framework LPI-deepGBDT to identify lncRNA-protein interactions [ 12 ]. Zhou et al proposed a hybrid framework LPI-HyADBS to predict lncRNA-protein interactions [ 13 ].…”

Inferring Latent Disease-lncRNA Associations by Label-Propagation Algorithm and Random Projection on a Heterogeneous Network

“…In recent years, deep learning has attracted increased attention from artificial intelligence communities (Lihong et al, 2021;Zhou et al, 2021a;Lihong et al (2021) and Zhou et al (2021b) (Xuan et al, 2019a), GCNLDA (Xuan et al, 2019c), CNNDLP (Xuan et al, 2019d), and LDAPred (Xuan et al, 2019b). Wu et al (2020) also predicted the potential association between lncRNA and disease by using a graph-convolutional network.…”